| Health / Medical Topics |
Serine/Threonine Kinase Inhibitor XL418
A selective, orally active small molecule, targeting protein kinase B (PKB or AKT) and ribosomal protein S6 Kinase (p70S6K), with potential antineoplastic activity. XL418 inhibits the activities of PKB and p70S6K, both acting downstream of phosphoinosotide-3 kinase (PI3K). These kinases are often upregulated in a variety of cancers. Inhibition of PKB by this agent will induce apoptosis, while inhibition of p70S6K will result in the inhibition of translation within tumor cells. (NCI Thesaurus)
YOU MAY ALSO LIKE
A peptide with G2 checkpoint-abrogating activity. G2 checkpoint inhibitor CBP501 inhibits multiple serine/threonine kinases, including MAPKAP-K2, C-Tak1, and CHK1, that phosphorylate serine…
Any substance that inhibits serine/threonine protein kinase, an enzyme that phosphorylates the hydroxyl group of serine or threonine on various proteins in…
Serine/arginine-rich splicing factor 3 (164 aa, ~19 kDa) is encoded by the human SRSF3 gene. This protein plays a role in mRNA…
Serine/arginine-rich splicing factor 2 (221 aa, ~25 kDa) is encoded by the human SRSF2 gene. This protein plays a role in the…
Serine-rich coiled-coil domain-containing protein 1 (900 aa, ~100 kDa) is encoded by the human CCSER1 gene. This protein may be involved in…
Serine-protein kinase ATM (3056 aa, ~351 kDa) is encoded by the human ATM gene. This protein is involved in DNA damage-induced protein…
